| Product Code: ETC10765414 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of pembrolizumab to Grenada in 2024 show a diverse sourcing landscape, with top exporting countries including Barbados, India, Panama, South Korea, and Belgium. The market concentration, as measured by the HHI, decreased from high to moderate in 2024, indicating a more balanced distribution of imports. The impressive compound annual growth rate (CAGR) of 24.01% from 2020 to 2024 highlights the increasing demand for this product in Grenada. Moreover, the substantial growth rate of 67.54% from 2023 to 2024 suggests a rapid expansion in the market for pembrolizumab in the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Pembrolizumab Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Pembrolizumab Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Pembrolizumab Market - Industry Life Cycle |
3.4 Grenada Pembrolizumab Market - Porter's Five Forces |
3.5 Grenada Pembrolizumab Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Grenada Pembrolizumab Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Grenada Pembrolizumab Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 Grenada Pembrolizumab Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Grenada Pembrolizumab Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 Grenada Pembrolizumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Grenada Pembrolizumab Market Trends |
6 Grenada Pembrolizumab Market, By Types |
6.1 Grenada Pembrolizumab Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Grenada Pembrolizumab Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 Grenada Pembrolizumab Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 Grenada Pembrolizumab Market Revenues & Volume, By Melanoma, 2021 - 2031F |
6.1.5 Grenada Pembrolizumab Market Revenues & Volume, By Head and Neck Cancer, 2021 - 2031F |
6.1.6 Grenada Pembrolizumab Market Revenues & Volume, By Bladder Cancer, 2021 - 2031F |
6.1.7 Grenada Pembrolizumab Market Revenues & Volume, By Hodgkin's Lymphoma, 2021 - 2031F |
6.2 Grenada Pembrolizumab Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Grenada Pembrolizumab Market Revenues & Volume, By PD-1 Inhibitor, 2021 - 2031F |
6.2.3 Grenada Pembrolizumab Market Revenues & Volume, By Immune Checkpoint Blockade, 2021 - 2031F |
6.2.4 Grenada Pembrolizumab Market Revenues & Volume, By T-Cell Activation, 2021 - 2031F |
6.2.5 Grenada Pembrolizumab Market Revenues & Volume, By Antibody-Based Therapy, 2021 - 2031F |
6.2.6 Grenada Pembrolizumab Market Revenues & Volume, By Tumor Microenvironment Modulation, 2021 - 2031F |
6.3 Grenada Pembrolizumab Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Grenada Pembrolizumab Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.3.3 Grenada Pembrolizumab Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.4 Grenada Pembrolizumab Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.3.5 Grenada Pembrolizumab Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.6 Grenada Pembrolizumab Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.4 Grenada Pembrolizumab Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Grenada Pembrolizumab Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Grenada Pembrolizumab Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 Grenada Pembrolizumab Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 Grenada Pembrolizumab Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Grenada Pembrolizumab Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 Grenada Pembrolizumab Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Grenada Pembrolizumab Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 Grenada Pembrolizumab Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 Grenada Pembrolizumab Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 Grenada Pembrolizumab Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
6.5.6 Grenada Pembrolizumab Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
7 Grenada Pembrolizumab Market Import-Export Trade Statistics |
7.1 Grenada Pembrolizumab Market Export to Major Countries |
7.2 Grenada Pembrolizumab Market Imports from Major Countries |
8 Grenada Pembrolizumab Market Key Performance Indicators |
9 Grenada Pembrolizumab Market - Opportunity Assessment |
9.1 Grenada Pembrolizumab Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Grenada Pembrolizumab Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Grenada Pembrolizumab Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 Grenada Pembrolizumab Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Grenada Pembrolizumab Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 Grenada Pembrolizumab Market - Competitive Landscape |
10.1 Grenada Pembrolizumab Market Revenue Share, By Companies, 2024 |
10.2 Grenada Pembrolizumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here